S'abonner

Maternal major depression during early pregnancy is associated with impaired child executive functioning at 4.5 years of age - 23/12/23

Doi : 10.1016/j.ajog.2023.11.1252 
Robert D. Levitan, MD, MSc a, b, c, , Leslie Atkinson, PhD d, Julia A. Knight, PhD e, f, Rayjean J. Hung, PhD e, f, Mark Wade, PhD g, Jennifer M. Jenkins, PhD h, Kashtin Bertoni, MPH i, Jody Wong, BSc(Hons) i, Kellie E. Murphy, MD, MSc i, j, k, Stephen J. Lye, PhD c, i, j, k, Stephen G. Matthews, PhD c, i, j, k
a Mood and Anxiety Disorders Program, Centre for Addiction and Mental Health, Ontario, Canada 
b Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada 
c Department of Physiology, University of Toronto, Toronto, Ontario, Canada 
d Department of Psychology, Toronto Metropolitan University, Toronto, Ontario, Canada 
e Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute of Sinai Health, Toronto, Ontario, Canada 
f Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada 
g Ontario Institute for Studies in Education, University of Toronto, Toronto, Ontario, Canada 
h Department of Applied Psychology and Human Development, University of Toronto, Ontario, Canada 
i Lunenfeld-Tanenbaum Research Institute of Sinai Health, Toronto, Ontario, Canada 
j Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada 
k Department of Obstetrics and Gynaecology, Mount Sinai Hospital, Toronto, Ontario, Canada 

Corresponding author: Robert D. Levitan, MD, MSc.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Saturday 23 December 2023
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Background

Maternal depression is a serious condition that affects up to 1 in 7 pregnancies. Despite evidence linking maternal depression to pregnancy complications and adverse fetal outcomes, there remain large gaps in its identification and treatment. More work is needed to define the specific timing and severity of depression that most urgently requires intervention, where feasible, to protect maternal health and the developing fetus.

Objective

This study aimed to examine whether the timing and severity of maternal depression and/or anxiety during pregnancy affect child executive functioning at age 4.5 years. Executive functioning in the preschool years is a strong predictor of both school readiness and long-term quality of life.

Study Design

This longitudinal observational pregnancy cohort study included a sample of 323 mother-child dyads taking part in the Ontario Birth Study, an open pregnancy cohort in Toronto, Ontario, Canada. Maternal symptoms of depression and anxiety were assessed at 12 to 16 and 28 to 32 weeks of gestation and at the time of child testing at age 4.5 years using the 4-item Patient Health Questionnaire. Child executive functioning was measured during a home visit using standardized computerized administration of the Flanker test (a measure of attention) and the Dimensional Change Card Sort (a measure of cognitive flexibility). Stepwise linear regressions, controlling for possible confounding variables, were used to assess the predictive value of continuous measures of maternal depression and/or anxiety symptoms at each assessment time on the Flanker test and Dimensional Change Card Sort. Posthoc general linear models were used to assess whether maternal depression severity categories (no symptom, mild symptoms, or probable major depressive disorder) were helpful in identifying children at risk.

Results

Across all children, after controlling for potential confounds, greater maternal depressive symptoms at weeks 12 to 16 weeks of gestation predicted worse performance on both the Flanker test (ΔR2=0.058; P<.001) and the Dimensional Change Card Sort (ΔR2=0.017; P=.018). Posthoc general linear modeling further demonstrated that the children of mothers meeting the screening criteria for major depression in early pregnancy scored 11.3% lower on the Flanker test and 9.8% lower on the Dimensional Change Card Sort than the children of mothers without maternal depressive symptoms in early pregnancy. Mild depressive symptoms had no significant effect on executive function scores. There was no significant effect of anxiety symptoms or maternal antidepressant use in early pregnancy or pandemic conditions or maternal symptoms in later pregnancy or at the time of child testing on either the Flanker or Dimensional Change Card Sort results.

Conclusion

This study demonstrated that fetal exposure to maternal major depression, but not milder forms of depression, at 12 to 16 weeks of gestation is associated with impaired executive functioning in the preschool years. Child executive functioning is crucial for school readiness and predicts long-term quality of life. This emphasizes an urgent need to improve the recognition and treatment of maternal major depression, particularly in early pregnancy, to limit its negative effects on the patient and on child cognitive development.

Le texte complet de cet article est disponible en PDF.

Video


(5.32 Mo)

Le texte complet de cet article est disponible en PDF.

Key words : child executive functioning, fetal programming, longitudinal pregnancy cohort study, maternal depression and anxiety, preschoolers, timing and severity


Plan


 The authors report no conflict of interest.
 This work was supported by the Canadian Institutes of Health Research (grant number: FDN 143262 to S.J.L. and grant number 452765 to R.D.L.); the Cameron Parker Holcombe Wilson Chair in Depression Studies, University of Toronto (to R.D.L.); the Lunenfeld-Tanenbaum Research Institute; the Department of Obstetrics and Gynecology, Sinai Health System; and the Mount Sinai Hospital Foundation.
 Cite this article as: Levitan RD, Atkinson L, Knight JA, et al. Maternal major depression during early pregnancy is associated with impaired child executive functioning at 4.5 years of age. Am J Obstet Gynecol 2023;XX:x.ex–x.ex.


© 2023  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.